Table 2.
Spectral titration of human P450 2C8, and 2C9 with fatty acids
Fatty acid | P450 2C8 | P450 2C9 | ||
---|---|---|---|---|
ΔAmaxa | Ksb (μM) | ΔAmax | Ks (μM) | |
C14:0 | 0.051 ± 0.001c | 8.0 ± 0.7c | 0.040 ± 0.002 | 13 ± 2 |
C16:0 | 0.044 ± 0.002 | 1.5 ± 0.6 | 0.055 ± 0.004 | 11 ± 2 |
C16:1 | 0.041 ± 0.003 | 7.9 ± 1.8 | 0.056 ± 0.005 | 8.7 ± 1.8 |
C18:1 | 0.027 ± 0.002 | 1.1 ± 0.7 | 0.046 ± 0.005 | 6.8 ± 2.1 |
C18:2 | 0.046 ± 0.003 | 0.5 ± 0.3 | 0.045 ± 0.002 | 0.8 ± 0.3 |
C20:4 | 0.062 ± 0.005 | 13 ± 3.0 | 0.037 ± 0.002 | 0.5 ± 0.3 |
C22:6 | –d | – | 0.042 ± 0.005 | 9.3 ± 2.6 |
Difference in absorbance between the wavelength maximum at 390 nm and minimum at 420 nm, ΔA390 – A420. The concentration range used was 0 to 50 μM fatty acid in each case.
Estimated from the hyperbolic fitting plot of ΔAmax versus the fatty acid concentration.
Data presented in Supporting Information Figure S-2.
–, no detectable binding (ΔA390 < 0.005 at 50 μM).